Gibson Dunn & Crutcher

Los Angeles-based Gibson Dunn & Crutcher offers an IP practice primarily focused on representing clients in contentious matters. The firm operates out of major markets in California including Palo Alto Century City and Orange County. This year the firm maintained a highly recommended ranking in California for patent litigation.

Key practitioners in the patent department include Century City-based partner Wayne Barsky, and co-head Josh Krevitt, who splits his practice between the New York and Palo Alto offices.

In 2021, the firm was shortlisted for Patent Contentious Firm of the Year in the United States for substantial activity in litigation across its national offices, including Los Angeles and Palo Alto.

On behalf of its clients EMD Serono and Pfizer, Gibson Dunn secured a defense victory in a patent infringement suit after a decade of litigation in which plaintiff Biogen sought more than $5.4 billion in damages. The Federal Circuit in 2020 reinstated the jury's verdict that the asserted claims of Biogen's are invalid as anticipated.

Recently, Gibson Dunn defended NetApp in patent infringement litigation in the District of Massachusetts brought by Intellectual Ventures on five patents directed to NetApp's data storage systems.

The firm also represents Fitbit in an ITC investigation brought by Philips, in which Philips alleges that Fitbit’s imported products infringe three of Philips’ patents.